Avid Bioservices Inc (CDMO)

[biopharm]

CJ, very nice! I'm not sure if "Ambit.." would be considered, since we have no 100% PR on that and we only have a Peregrine Pharmaceuticals employee with a linkedin profile = Tom Sklenar that also shows employed by Ambit...

------------

Current
Ambit Biosciences,
Peregrine Pharmaceuticals


Sr. Clinical Trial Manager
Ambit Biosciences: January 2014 – Present (2 months)

Sr. Clinical Trial Manager
Peregrine Pharmaceuticals August 2011 – Present (2 years 7 months)

And for those that like to make BMY connections:

Mark Foletta, (ex Amylin before BMY deal in 2012) was appointed to the board of Ambit Biosciences in the same month (JAN 2014) that Tom Sklenar started his double employment (PPHM+Ambit)

http://investorshub.advfn.com/boards/read_msg.aspx?message_id=114368100

------------------

To be honest, IF IF Ambit is close to BMS and it seems like Peregrine tries to stay far clear away from BMS/Opdivo now... maybe Ambit does not mean much at all

It still makes me think back of the Medarex <> PPHM collaboration back in 2005 and what if Medarex used CSM in Fargo ND back during those early years and is it out of the realm of possibility that BMS sort of knew the value of Opdivo+Bavituximab way back then.

I'm not sure... but just strange how BMS buys out Medarex and moves forward with Opdivo and with all the sabotage rooted back to CSM in Fargo ND, maybe BMS had plans all along to try and dominate market share with Opdivo+Bavituximab all by themselves, but know Bavituximab is in the hands of dozens of collaborators and possibly completely backfired on BMS

------------------

Nivolumab (nye vol' ue mab; ONO-4538, BMS-936558, or MDX1106), marketed as Opdivo, is a human IgG4 anti-PD-1 monoclonal antibody developed by Ono Pharmaceutical and Medarex (later acquired by Bristol-Myers Squibb) for the treatment of cancer.[1][2] Nivolumab acts as an immunomodulator by blocking ligand activation of the programmed cell death 1 (PD-1) receptor on activated T cells.

https://en.wikipedia.org/wiki/Nivolumab

http://ignition.co/327

---------------

2005 Peregrine and Medarex

http://ir.peregrineinc.com/releasedetail.cfm?ReleaseID=266115